Cargando…

The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features

Detalles Bibliográficos
Autores principales: Aloia, Andrea, Petrova, Evgeniya, Agorku, David, Terranegra, Annalisa, Mingione, Alessandra, Judde, Jean-Gabriel, Bosio, Andreas, Cairo, Stefano, Hardt, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547330/
http://dx.doi.org/10.1186/2051-1426-3-S1-O1
_version_ 1782387058314051584
author Aloia, Andrea
Petrova, Evgeniya
Agorku, David
Terranegra, Annalisa
Mingione, Alessandra
Judde, Jean-Gabriel
Bosio, Andreas
Cairo, Stefano
Hardt, Olaf
author_facet Aloia, Andrea
Petrova, Evgeniya
Agorku, David
Terranegra, Annalisa
Mingione, Alessandra
Judde, Jean-Gabriel
Bosio, Andreas
Cairo, Stefano
Hardt, Olaf
author_sort Aloia, Andrea
collection PubMed
description
format Online
Article
Text
id pubmed-4547330
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45473302015-09-10 The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features Aloia, Andrea Petrova, Evgeniya Agorku, David Terranegra, Annalisa Mingione, Alessandra Judde, Jean-Gabriel Bosio, Andreas Cairo, Stefano Hardt, Olaf J Immunother Cancer Oral Presentation BioMed Central 2015-08-14 /pmc/articles/PMC4547330/ http://dx.doi.org/10.1186/2051-1426-3-S1-O1 Text en Copyright © 2015 Aloia et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Aloia, Andrea
Petrova, Evgeniya
Agorku, David
Terranegra, Annalisa
Mingione, Alessandra
Judde, Jean-Gabriel
Bosio, Andreas
Cairo, Stefano
Hardt, Olaf
The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
title The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
title_full The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
title_fullStr The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
title_full_unstemmed The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
title_short The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
title_sort sialyl-glycolipid ssea4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547330/
http://dx.doi.org/10.1186/2051-1426-3-S1-O1
work_keys_str_mv AT aloiaandrea thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT petrovaevgeniya thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT agorkudavid thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT terranegraannalisa thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT mingionealessandra thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT juddejeangabriel thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT bosioandreas thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT cairostefano thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT hardtolaf thesialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT aloiaandrea sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT petrovaevgeniya sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT agorkudavid sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT terranegraannalisa sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT mingionealessandra sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT juddejeangabriel sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT bosioandreas sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT cairostefano sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures
AT hardtolaf sialylglycolipidssea4marksasubpopulationofchemotherapyresistantbreastcancercellswithmesenchymalfeatures